Active

Contract Opportunity

NOTICE OF INTENT TO SOLE SOURCE
Department of Veterans Affairs
VA Palo Alto Health Care System (VAPAHCS)
Acquisition ID#: 36C261 26 AP 4343

The Department of Veterans Affairs, VA Palo Alto Health Care System (VAPAHCS), intends to award a Firm Fixed Price sole source contract to Novogene Corporation Inc. for single cell 3 RNA sequencing (scRNA seq) on fresh human cell samples, including full library preparation, sequencing, quality control, and downstream bioinformatics analysis.

Authority
This acquisition will be conducted under FAR 13.106 1(b)(1), soliciting from a single source when the contracting officer determines that only one source is reasonably available.

Description of Requirement
VAPAHCS Research Service requires highly specialized 10x Genomics single cell RNA sequencing, including:
Local same day pickup and immediate processing of fresh human samples to preserve RNA integrity
Sample QC
10x Genomics library preparation
Sequencing on the Ultima UG100 platform targeting 400 million raw reads per sample
Full bioinformatics pipeline: demultiplexing, alignment, cell calling, clustering, HVG identification, marker gene detection, enrichment analysis
Secure data return via SFTP
All work performed at contractor s Sacramento, CA laboratory
This work supports ongoing transcriptional level disease biology research requiring advanced single cell resolution.
Estimated value: $18,171.00 (Firm Fixed Price)
Period of Performance
One (1) year from date of award, consistent with the supporting justification package.

Not a Request for Quotes
This notice is not a request for competitive quotes. However, interested parties may submit capability statements demonstrating they can meet every mandatory technical requirement. Send information to Rachael.Becker@va.gov. Contractors who do not provide the ability to perform the requirements identified below will not be considered responsive. The Government will use responses solely to determine if a competitive opportunity exists.

Response Requirements
Respondents must demonstrate:
Ability to process fresh human samples same day, locally, without degradation
Access to the Ultima UG100 platform
Full 10x single cell workflow capability
Full bioinformatics workflow
Ability to meet the turnaround time and sample handling constraints
Proof of relevant authorization and technical capability

Only responses demonstrating complete equivalence will be considered.

Attachments/Links